News tagged with clopidogrel
Do blood thinners + stroke treatment = danger? Study indicates the risk is low
Millions of Americans take aspirin or other drugs every day to reduce their risk of heart attacks or other problems caused by blood clots.
Cardiology
Mar 13, 2013 |
not rated yet |
0
|
Novel anti-clotting drug more effective than Plavix in coronary procedures, study says
(Medical Xpress)—An experimental drug has been shown to be significantly more effective at preventing blood clots during coronary stenting procedures compared to the anti-clotting agent now typically used, according to ...
Cardiology
Mar 11, 2013 |
not rated yet |
0
|
Administration of clopidogrel prior to PCI associated with reduction in major cardiac events
Among patients scheduled for a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), pretreatment with the antiplatelet agent clopidogrel ...
Cardiology
Dec 18, 2012 |
not rated yet |
0
|
Some heart patients may respond differently to anti-platelet drugs
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke ...
Cardiology
Nov 05, 2012 |
not rated yet |
0
|
Year of taking risky blood thinners may be unnecessary after stent surgery
(HealthDay)—A full year of aggressive anti-clotting therapy—which can lead to heavy bleeding—may not be needed after surgery to implant a drug-coated cardiac stent, two new studies suggest.
Cardiology
Sep 20, 2012 |
not rated yet |
0
|
Aspirin-clopidogrel no better than aspirin alone for patients with lacunar stroke
Aspirin combined with the antiplatelet drug clopidogrel is no better than aspirin alone for stroke prevention in people with a history of lacunar strokes, and the combination carries a greater risk of gastrointestinal bleeding, ...
Cardiology
Aug 29, 2012 |
not rated yet |
0
|
Anti-clotting drugs yield similar results
The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs – prasugrel and clopidogrel – in preventing ...
Cardiology
Aug 26, 2012 |
not rated yet |
0
|
Study reports validation of the first point-of-care genetic test in medicine, regarding use of antiplatelet therapy
A study published Online First by the Lancet reports the successful validation and clinical application of the first point-of-care genetic test in medicine. The test successfully identifies the CYP2C19*2 allele: a common ...
Cardiology
Mar 28, 2012 |
not rated yet |
0
|
New class of platelet blockers proves effective in phase III trial
Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the risk of recurrent cardiovascular events in patients with known atherosclerosis, a hardening and narrowing of ...
Cardiology
Mar 26, 2012 |
not rated yet |
0
|
Complications in patients undergoing percutaneous coronary intervention tend to occur within first 30 days
Percutaneous coronary intervention (PCI), also known as coronary angioplasty or angioplasty, is a procedure used to treat acute coronary syndromes. PCI involves opening a blocked blood vessel by threading and inflating a ...
Cardiology
Mar 24, 2012 |
not rated yet |
0
|
Analysis does not support genetic test before use of anti-clotting drug
Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may ...
Genetics
Dec 27, 2011 |
not rated yet |
0
|
World's first bedside genetic test proves effective
Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) ...
Genetics
Nov 09, 2011 |
not rated yet |
0
|
Researchers find gene variants that cause stent thrombosis in people with coronary artery disease
In a first-of-its-kind study, researchers from Mount Sinai School of Medicine have discovered several gene variants contributing to early stent thrombosis (ST), a devastating and often deadly complication after coronary stent ...
Genetics
Oct 25, 2011 |
not rated yet |
0
|
One in five heart-attack deaths could be prevented with new drug
Robert Storey, Professor of Cardiology at the University of Sheffield's Department of Cardiovascular Science, presented findings today that confirm one in five deaths in the year following a heart attack could be prevented ...
Cardiology
Jun 13, 2011 |
not rated yet |
0
|
Omega-3 may cut risk of artery disease, heart attacks for patients with stents
Omega-3 fatty acids, combined with two blood-thinning drugs, significantly changed the blood-clotting process and may reduce the risk of heart attacks in patients with stents in their heart arteries, according to research ...
Cardiology
May 26, 2011 |
4 / 5 (1) |
0
|
Clopidogrel
Clopidogrel is an oral, thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. The drug works by irreversibly inhibiting a receptor called P2Y12, an adenosine diphosphate ADP chemoreceptor. Adverse effects include hemorrhage, severe neutropenia, and thrombotic thrombocytopenic purpura (TTP).
For more information about Clopidogrel, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
